Download presentation
Presentation is loading. Please wait.
Published byHarold Merritt Modified over 4 years ago
1
International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous? Heinrich Körtke, MD, Reiner Körfer, MD The Annals of Thoracic Surgery Volume 72, Issue 1, Pages (July 2001) DOI: /S (01)02656-X
2
Fig 1 Early mortality according to valve position and study group. (AVR = aortic valve replacement; MVR = mitral valve replacement.) The Annals of Thoracic Surgery , 44-48DOI: ( /S (01)02656-X)
3
Fig 2 Late mortality according to valve position and study group. (Abbreviations as in Figure 1.) The Annals of Thoracic Surgery , 44-48DOI: ( /S (01)02656-X)
4
Fig 3 Distribution of study drop-outs. ∗∗∗p ≤ 0.001.
The Annals of Thoracic Surgery , 44-48DOI: ( /S (01)02656-X)
5
Fig 4 Reasons for study drop-outs.
The Annals of Thoracic Surgery , 44-48DOI: ( /S (01)02656-X)
6
Fig 5 Distribution of risk factors between the two groups. 1 Men, body weight 15% higher than normal; women, body weight 10% higher than normal. 2 Blood pressure greater than 150/60 mm Hg. (AF = artrial fibrillation; n.s. = not significant.) ∗p ≤ 0.05. The Annals of Thoracic Surgery , 44-48DOI: ( /S (01)02656-X)
7
Fig 6 ESCAT-1 observation period for 600 patients.
The Annals of Thoracic Surgery , 44-48DOI: ( /S (01)02656-X)
8
Fig 7 Percentages within the therapeutic international normalized ratio (INR) range. (∗∗p ≤ 0.01; ∗∗∗p ≤ ) The Annals of Thoracic Surgery , 44-48DOI: ( /S (01)02656-X)
9
Fig 8 Grade III complications, with a significant difference (∗p = 0.04) between the two groups. The Annals of Thoracic Surgery , 44-48DOI: ( /S (01)02656-X)
10
Fig 9 Freedom from grade III thromboembolic or hemorrhagic complications. (post op = postoperative; cum. = cumulative.) The Annals of Thoracic Surgery , 44-48DOI: ( /S (01)02656-X)
11
Fig 10 Course of grade III complications during 24 months postoperatively. The Annals of Thoracic Surgery , 44-48DOI: ( /S (01)02656-X)
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.